Cart
sales@molnova.com
Setmelanotide TFA
CAS No.
Setmelanotide TFA ( RM-493 TFA; BIM-22493 TFA; IRC-022493 TFA )
Catalog No. M29740 CAS No.
Setmelanotide TFA (RM-493 TFA; BIM-22493 TFA; IRC-022493 TFA) is a selective melanocortin 4 receptor (MC4R) agonist.
Setmelanotide TFA (RM-493 TFA; BIM-22493 TFA; IRC-022493 TFA) is a selective melanocortin 4 receptor (MC4R) agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameSetmelanotide TFA
-
NoteResearch use only, not for human use.
-
Brief DescriptionSetmelanotide TFA (RM-493 TFA; BIM-22493 TFA; IRC-022493 TFA) is a selective melanocortin 4 receptor (MC4R) agonist.
-
DescriptionSetmelanotide TFA (RM-493 TFA; BIM-22493 TFA; IRC-022493 TFA) is a selective melanocortin 4 receptor (MC4R) agonist.
-
In Vitro
-
In Vivo
-
SynonymsRM-493 TFA; BIM-22493 TFA; IRC-022493 TFA
-
PathwayOthers
-
TargetOther Targets
-
RecptorEC50: 5.8 nM (hMC1R), 5.3 nM (hMC3R), 0.27 nM (hMC4R), 0.28 nM (rMC4R), 1600 nM (hMC5R)
-
Research Area
-
Indication
Chemical Information
-
CAS Number--
-
Formula Weight1231.33
-
Molecular FormulaC51H69F3N18O11S2
-
Purity>98% (HPLC)
-
Solubility
-
SMILES
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Kumar KG, et al. Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice. Peptides. 2009 Oct;30(10):1892-900.
molnova catalog
related products
-
Argipressin
Argipressin is a peptide hormone with vasoconstrictive and antidiuretic activities that binds to the vascular arginine vasopressin receptor V1 with Kd values of 1.31 and 1.44 nM in A7r5 rat aortic smooth muscle cells and neonatal rat cardiomyocytes respectively.
-
Toddaculin
Toddaculine may be beneficial for the prevention and treatment of osteoporosis, it can not only inhibit the differentiation of osteoclasts via activation of the NF-κB, ERK 1/2, and p38 MAPK signaling pathways.
-
4-Quinolinecarboxyli...
4-Quinolinecarboxylic acid showed anti-tumor activity against L1210 leukemia and B16 melanoma.
